Streamlining Neurology Prior Authorizations with Surescripts Integration
Klivira's advanced **neurology Surescripts integration** empowers clinics and health systems to dramatically accelerate prior authorization workflows for complex neurological treatments.
Neurology practices face a uniquely high volume of prior authorizations for specialty drugs, advanced imaging, and interventional procedures. Managing these PAs manually strains revenue cycles and delays patient access to critical therapies. Klivira leverages Surescripts ePA capabilities to automate and streamline these intricate processes, ensuring faster approvals and improved operational efficiency.
The Challenge: High-Volume Specialty Drug PAs in Neurology
Neurology prior authorization is heavily concentrated in high-cost, high-complexity specialty drugs. These include MS disease-modifying therapies (DMTs), CGRP migraine biologics, Alzheimer's disease therapeutics, and treatments for spinal muscular atrophy (SMA) and ALS. Each often requires extensive clinical documentation, adherence to step therapy protocols, and frequent re-authorizations, creating significant administrative overhead.
Accelerating Prior Authorization for Key Neurology Therapies via Surescripts ePA
Klivira's **neurology Surescripts integration** directly addresses the burden of specialty drug PAs. By connecting prescribers, pharmacies, PBMs, and health plans, the platform facilitates electronic prior authorization (ePA) submissions for medications that frequently trigger PA requirements. This includes high-efficacy MS DMTs, anti-amyloid antibodies for Alzheimer's, and CGRP monoclonal antibodies for migraine prevention.
Neurology Medications and Conditions Benefiting from Surescripts ePA
- **MS Disease-Modifying Therapies (DMTs)**: Ocrelizumab, ofatumumab, natalizumab, and oral DMTs often require stringent PA.
- **Alzheimer's Disease Therapeutics**: Lecanemab, donanemab, and similar anti-amyloid antibodies with complex documentation needs.
- **Migraine Prevention Biologics** (CGRP monoclonal antibodies): Erenumab, fremanezumab, galcanezumab, eptinezumab, and oral gepants.
- **Spinal Muscular Atrophy / ALS Treatments**: Nusinersen, onasemnogene abeparvovec, risdiplam, edaravone, tofersen.
- **Epilepsy Specialty Drugs**: Cenobamate, brivaracetam, lacosamide, cannabidiol for specific indications.
Navigating Documentation and Step Therapy with Integrated Workflows
Neurology prior authorizations are often denied due to gaps in documentation or non-compliance with step therapy. Klivira's integration with Surescripts ePA streamlines the submission of required clinical data, such as McDonald criteria for MS, amyloid confirmation for AD, or prior preventive trials for CGRP migraine. The platform embeds AAN Practice Guidelines-aware logic to guide staff through payer-specific requirements, mitigating common denial reasons like step therapy for MS DMTs or amyloid biomarker confirmation gaps for AD anti-amyloid antibodies.
Klivira's Intelligent Automation for Neurology ePA
Beyond Surescripts ePA, Klivira's platform provides comprehensive automation tailored for neurology. This includes tracking periodic re-authorization for chronic treatments, such as MS DMTs, and managing the documentation for ongoing MRI monitoring requirements often associated with these therapies. Our solution integrates with your EMR to pull relevant clinical data, auto-populating forms and reducing manual data entry for both initial and renewal authorizations.
Frequently asked questions
How does Surescripts integration specifically help with prior authorizations for MS DMTs?
Surescripts ePA facilitates the electronic submission of prior authorization requests for MS disease-modifying therapies. Klivira augments this by automating the collection of necessary clinical evidence, such as McDonald criteria, EDSS scores, and prior DMT trials, directly from the EMR, ensuring compliance with payer step therapy requirements and AAN guidelines.
Can Surescripts ePA handle the complex documentation for Alzheimer's anti-amyloid therapies?
While Surescripts ePA provides the electronic channel for submission, Klivira's platform specializes in gathering the complex documentation required for Alzheimer's anti-amyloid antibodies. This includes confirming clinical AD diagnosis, amyloid confirmation (PET or CSF), MRI for ARIA screening, and ApoE genotyping, which are critical for approval and often a source of denial if incomplete.
Does Surescripts integration also cover prior authorizations for advanced imaging like brain MRIs?
Surescripts ePA is primarily designed for prescription medications. Prior authorizations for advanced imaging, such as brain MRIs or amyloid PET scans, typically fall under medical benefit PAs and are processed through different channels (e.g., X12 278 transactions or payer portals). Klivira's platform supports these medical benefit PAs independently, integrating with EMRs and various payer channels to manage all types of neurology authorizations.
How does Klivira address the need for periodic re-authorizations in neurology via Surescripts?
Many neurology specialty drugs, like MS DMTs and CGRP biologics, require periodic re-authorization. Klivira's system tracks these re-authorization cycles, proactively initiating the ePA process through Surescripts before expiration. It leverages stored patient data and updated clinical information from the EMR to streamline renewal submissions, minimizing treatment disruptions.
What EMR touchpoints are integrated for neurology Surescripts ePA?
Klivira integrates with your EMR via SMART on FHIR and other APIs to pull relevant patient demographics, diagnoses, medication history, and clinical notes directly into the Surescripts ePA workflow. This automation reduces manual data entry, ensures accuracy, and accelerates the submission of prior authorization requests for neurology drugs ordered within the EMR.
Related coverage
Other neurology prior auth workflows
- Streamlining Neurology Inpatient Admission Prior Auth
- Optimize Neurology AIM Specialty Health Integration for Prior Authorization
- Accelerating Neurology Availity Integration for Prior Authorization
- Automating Neurology Biologics Prior Auth for Faster Patient Access
- Streamlining Neurology CVS Caremark Integration for Prior Authorization Workflows
- Optimizing Neurology CGM Prior Auth Workflows
- Streamlining Neurology Prior Authorizations with Change Healthcare Clearinghouse Integration
- Automating Neurology Claim Status Tracking for Complex Neuro Therapies
- Achieving Neurology CMS-0057-F Compliance with Klivira
- Optimizing Neurology Prior Authorization with Cohere Health
- Automating Neurology Batch Eligibility (270/271) for Complex Therapies
- Seamless Neurology CoverMyMeds Integration for Prior Authorization Efficiency
- Optimizing Neurology CPAP / BiPAP Prior Auth Workflows
- Transforming Neurology Prior Authorization with Da Vinci PAS
- Accelerating Neurology Denial Appeal Automation
- Optimizing Neurology Denial Management with Klivira
- Optimizing Neurology Eligibility Verification for Complex Therapies
- Optimizing Neurology ePA via NCPDP SCRIPT for Specialty Therapies
- Optimizing Neurology Prior Authorization Workflows with Epic Orchestrate
- Optimizing Neurology eviCore Integration for Complex Neuro Therapies
- Optimizing Neurology Prior Authorization with Experian Health Clearinghouse
- Optimizing Neurology Express Scripts Integration for Prior Authorization
- Streamlining Neurology Fax & Paper Form Automation
- Accelerating Neurology GLP-1 Prior Auth with Klivira
- Transforming Neurology Imaging Prior Auth Workflows
- Klivira for Neurology Inovalon Clearinghouse Workflows
- Optimizing Neurology InterQual Criteria Application with Klivira
- Optimize Neurology Prior Authorizations with Magellan Healthcare
- Streamlining Neurology Prior Authorizations with MCG Criteria
- Streamlining Neurology Carelon Prior Authorizations
- Optimizing Neurology Naviguard Prior Authorizations
- Streamlining Neurology NIA Magellan Integration for Advanced Imaging PAs
- Automating Neurology Observation vs Inpatient Status Determinations
- Seamless Neurology Olive AI Replacement with Klivira
- Automating Neurology Oncology Pathways Prior Auth
- Accelerating Neurology OptumRx Integration for Specialty Pharmacy PAs
- Revolutionizing Neurology Payer Portal Automation for Complex Therapies
- Automating Neurology Peer-to-Peer Scheduling for Complex Cases
- Transforming Neurology Prior Authorization Automation
- Streamlining Neurology Real-Time Eligibility (270/271) for Complex Therapies
- Revolutionizing Neurology Prior Auth with SMART on FHIR Integration
- Automating Neurology Specialty Drug Prior Auth for Complex Therapies
- Optimizing Neurology Prior Authorization with Cognizant TriZetto
- Streamlining Neurology 7-Day Urgent Prior Auth Workflows
- Optimize Neurology Prior Authorizations with Waystar Clearinghouse Integration
- Optimizing Neurology X12 278 Prior Auth Workflows
Ready to automate this workflow for this specialty?
See how Klivira automates prior authorizations for your team.
Request a demo